Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: An analysis using the General Practice Research Database

Vaccine

Volumn 30, Issue 14, 2012, Pages 2483-2489

  Sammon, Cormac J ^a   McGrogan, Anita ^a   Snowball, Julia ^a   de Vries, Corinne S ^a  

^a University of Bath   (United Kingdom)

Author keywords

Coverage; Influenza; Influenza A virus H1N1 subtype; Influenza vaccine; Mass vaccination; Pandemics

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COMORBIDITY; DRUG UPTAKE; FEMALE; GUILLAIN BARRE SYNDROME; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; PANDEMIC INFLUENZA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT; SCHOOL CHILD; SEASONAL INFLUENZA; UNITED KINGDOM; VACCINATION;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 84858279914     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.11.077     Document Type: Article

References (48)

1. Monto A.S. Epidemiology of influenza. Vaccine 2008, 26(September (Suppl. 4)):D45-D48.
2. Nicoll A., Ciancio B., Tsolova S., Blank P., Yilmaz C. The scientific basis for offering seasonal influenza immunisation to risk groups in Europe. Euro Surveill 2008, 13.(October (43)).
3. Blank P.R., Szucs T.D. Increasing influenza vaccination coverage in recommended population groups in Europe. Expert Rev Vaccines 2009, 8(4):425-433.
4. Ropero-Alvarez A.M., Kurtis H.J., novaro-Holliday M.C., Ruiz-Matus C., Andrus J.K. Expansion of seasonal influenza vaccination in the Americas. BMC Public Health 2009, 9:361.
5. Fiore A.E., Shay D.K., Broder K., et al. Prevention and control of seasonal influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58(RR-8):1-52.
6. An Advisory Committee Statement (ACS), National Advisory Committee on Immunization (NACI). Statement on Seasonal Trivalent Inactivated Influenza Vaccine (TIV) for 2009-2010. Canada Communicable Disease Report 2010;35.
7. National Health and Medical Research Council (Australia), Nolan T., Immunise Australia Program, et al. The Australian immunisation handbook 2008, NHMRC, Canberra. 9th ed.
8. van Essen G.A., Palache A.M., Forleo E., Fedson D.S. Influenza vaccination in 2000: recommendations and vaccine use in 50 developed and rapidly developing countries. Vaccine 2003, 21(May (16)):1780-1785.
9. World Health Organisation Strategic advisory group of experts on immunization-report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic. Wkly Epidemiol Rec 2009, 84(July (30)):213-219.
10. European Centre for Disease Prevention and Control. ECDC Interim Risk Assessment: Influenza A (H1N1) 2009 pandemic. European Centre for Disease Prevention and Control 2009 [cited 2010 September 20]. Available from: URL: http://www.reliefweb.int/rw/RWFiles2009.nsf/FilesByRWDocUnidFilename/SODA-7U5TH8-full_report.pdf/$File/full_report.pdf.
11. Centers for Disease Control and Prevention Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009, 58(August (RR-10)):1-8.
12. Mereckiene J., Cotter S., Nicoll A., et al. National seasonal influenza vaccination survey in Europe. Euro Surveill 2008, 13.(October (43)).
13. Begum F, Pebody R. Influenza vaccine uptake among the 65 years and over and under 65 years at risk in England, Winter season 2008-2009. Department of Health (UK) 2009 [cited 2010 April 28]. Available from: URL: http://www.immunisation.nhs.uk/publications/FluVaccineUptake_Winter0809.pdf.
14. Begum F, Pebody R. Seasonal influenza vaccine uptake among the 65 years and over and under 65 years at risk in England - Winter season 2009-2010. Department of Health (UK) 2010 [cited 2010 September 20]. Available from: URL: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_118645.pdf.
15. Endrich M.M., Blank P.R., Szucs T.D. Influenza vaccination uptake and socioeconomic determinants in 11 European countries. Vaccine 2009, 27(30):4018-4024.
16. Kohlhammer Y., Schnoor M., Schwartz M., Raspe H., Schafer T. Determinants of influenza and pneumococcal vaccination in elderly people: a systematic review. Public Health 2007, 121(October (10)):742-751.
17. Chen Y., Yi Q.L., Wu J., Li F. Chronic disease status, self-perceived health and hospital admissions are important predictors for having a flu shot in Canada. Vaccine 2007, 25(October (42)):7436-7440.
18. Muller D., Szucs T.D. Influenza vaccination coverage rates in 5 European countries: a population-based cross-sectional analysis of the seasons 02/03, 03/04 and 04/05. Infection 2007, 35(October (5)):308-319.
19. Jimenez-Garcia R., Hernandez-Barrera V., de Andres A.L., Jimenez-Trujillo I., Esteban-Hernandez J., Carrasco-Garrido P. Gender influence in influenza vaccine uptake in Spain: time trends analysis (1995-2006). Vaccine 2010, 28(August (38)):6169-6175.
20. Coupland C., Harcourt S., Vinogradova Y., et al. Inequalities in uptake of influenza vaccine by deprivation and risk group: time trends analysis. Vaccine 2007, 25(42):7363-7371.
21. Rodriguez-Rieiro C., Dominguez-Berjon M.F., Esteban-Vasallo M.D., et al. Vaccination coverage against 2009 seasonal influenza in chronically ill children and adults: analysis of population registries in primary care in Madrid (Spain). Vaccine 2010, 28(August (38)):6203-6209.
22. Breeze E., Mangtani P., Fletcher A.E., Price G.M., Kovats S., Roberts J. Trends in influenza vaccination uptake among people aged over 74 years, 1997-2000: survey of 73 general practices in Britain. BMC Fam Pract 2004, 5:8.
23. Lu P.J., Singleton J.A., Rangel M.C., Wortley P.M., Bridges C.B. Influenza vaccination trends among adults 65 years or older in the United States, 1989-2002. Arch Intern Med 2005, 165(September (16)):1849-1856.
24. Centers for Disease Control and Prevention Racial/ethnic disparities in influenza and pneumococcal vaccination levels among persons aged > or =65 years - United States, 1989-2001. MMWR (Morb Mortal Wkly Rep) 2003, 52(October (40)):958-962.
25. Poland G.A. The 2009-2010 influenza pandemic: effects on pandemic and seasonal vaccine uptake and lessons learned for seasonal vaccination campaigns. Vaccine 2010, 28(September (Suppl. 4)):D3-D13.
26. Centers for Disease Control and Prevention Interim results: state-specific influenza A (H1N1) 2009 monovalent vaccination coverage - United States, October 2009-January 2010. MMWR (Morb Mortal Wkly Rep) 2010, 59(April (12)):363-368.
27. Centers for Disease Control Prevention Interim results: state-specific seasonal influenza vaccination coverage - United States August 2009-January 2010. MMWR (Morb Mortal Wkly Rep) 2010, 59(April (16)):477-484.
28. Begum F, Pebody R. Pandemic H1N1 (Swine) Influenza Vaccine Uptake amongst Patient Groups in Primary Care in England 2009/10. Department of Health (UK) 2010 [cited 2010 November 12]. Available from: URL: http://www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/@dh/@en/@ps/documents/digitalasset/dh_121014.pdf.
29. Wood L., Martinez C. The general practice research database: role in pharmacovigilance. Drug Saf 2004, 27(12):871-881.
30. Facts and Figures General Practice Research Database 2011 [cited 2011 January 12]. Available from: URL: http://www.gprd.com/gprd/factsandfigures.asp.
31. PRIMIS+. Influenza A. (H1N1)v Uptake Survey 2009/10, ImmForm, Read Codes Version 1.0 (excluding pregnancy). Department of Health 2010 [cited 2010 May 11]. Available from: URL: http://www.dh.gov.uk/en/Publichealth/Flu/Swineflu/InformationandGuidance/Vaccinationprogramme/DH_107355.
32. Townsend P., Beattie A., Phillimore P. Health and deprivation inequality and the north 1988, Croom Helm, London.
33. Noble M, McLennan D, Wilkinson K, Whitworth A, Barnes H. The English Indices of Multiple Deprivation 2007. Communities and Local Government: London, Social Disadvantage Research Centre, University of Oxford 2008 [cited 2010 September 21]. Available from: URL: http://www.communities.gov.uk/publications/communities/indicesdeprivation07.
34. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004, 159(April (7)):702-706.
35. Kroneman M., van Essen G.A., John P.W. Influenza vaccination coverage and reasons to refrain among high-risk persons in four European countries. Vaccine 2006, 24(January (5)):622-628.
36. Mangtani P., Breeze E., Stirling S., Hanciles S., Kovats S., Fletcher A. Cross-sectional survey of older peoples' views related to influenza vaccine uptake. BMC Public Health 2006, 6:249.
37. Holm M.V., Blank P.R., Szucs T.D. Developments in influenza vaccination coverage in England, Scotland and Wales covering five consecutive seasons from 2001 to 2006. Vaccine 2007, 25(46):7931-7938.
38. Kwong J.C., Rosella L.C., Johansen H. Trends in influenza vaccination in Canada, 1996/1997 to 2005. Health Rep 2007, 18(4):9-19.
39. Jimenez-Garcia R., Rodriguez-Rieiro C., Hernandez-Barrera V., et al. Effectiveness of age-based strategies to increase influenza vaccination coverage among high risk subjects in Madrid (Spain) 1. Vaccine 2011, 29(April (16)):2840-2845.
40. Honkanen P.O., Keistinen T., Kivela S.L. The impact of vaccination strategy and methods of information on influenza and pneumococcal vaccination coverage in the elderly population. Vaccine 1997, 15(3):317-320.
41. CDC's Advisory Committee on Immunization Practices (ACIP) Recommends Universal Annual Influenza Vaccination. CDC Division of Media Relations 2010 February 24 [cited 2011 January 17]. Available from: URL: http://www.cdc.gov/media/pressrel/2010/r100224.htm.
42. Louie J.K., Acosta M., Winter K., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A (H1N1) infection in California. JAMA 2009, 302(November (17)):1896-1902.
43. Centers for Disease Control Prevention Intensive-care patients with severe novel influenza A (H1N1) virus infection - Michigan June 2009. MMWR (Morb Mortal Wkly Rep) 2009, 58(July (27)):749-752.
44. Norbury M., Fawkes N., Guthrie B. Impact of the GP contract on inequalities associated with influenza immunisation: a retrospective population-database analysis 2. Br J Gen Pract 2011, 61(July (588)):e379-e385.
45. Stowe J., Andrews N., Wise L., Miller E. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenza like illness using the United Kingdom General Practice Research Database 1. Am J Epidemiol 2009, 169(February (3)):382-388.
46. Dieleman J., Romio S., de Vries C.S., Sammon C.J., Andrews N., Hviid A. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe 1. BMJ 2011, 343:d3908.
47. Rodriguez-Rieiro C., Esteban-Vasallo M.D., Dominguez-Berjon M.F., et al. Coverage and predictors of vaccination against 2009 pandemic H1N1 influenza in Madrid, Spain. Vaccine 2011, 29(February (6)):1332-1338.
48. European Commission Proposal for a Council recommendation on seasonal influenza vaccination. COM(2009) 353 final/2 2011 [cited 2011 September 12]. Available from: URL: http://ec.europa.eu/health/ph_threats/com/Influenza/docs/seasonflu_rec2009_en.pdf.